<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Human β-Hexosaminidase</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><surname>Id14-Eh1</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie -Kristallographie Takustr</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Steffi</forename><surname>Arzt</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie -Kristallographie Takustr</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Norbert</forename><surname>Straeter</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie -Kristallographie Takustr</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Timm</forename><surname>Maier</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie -Kristallographie Takustr</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Berlin</forename><surname>Fu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institut für Chemie -Kristallographie Takustr</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Human β-Hexosaminidase</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">9CA0CBC9873E2F55389F0FF63E41EE45</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T22:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>β-Hexosaminidase is a lysosomal hydrolase that cleaves terminal non-reducing β-Nacetylhexosamines from a broad range of substances e.g. glycolipids and glycoproteins. Mammalian β-hexosaminidases occur as two major isoforms: HexA, a heterodimer of the closely related α-and β-chains, and HexB, a homodimer ( ββ ). Mutations in the gene encoding the β-chain of β-hexosaminidase are the primary cause of Sandhoff disease, a fatal inborn error of metabolism. Datasets were collected in high and low resolution shells for human β-hexosaminidase recombinantly expressed in insect cells as well as an inhibitor complex of the protein. We were not able to process 4 out of the 5 collected datasets: Though indexing using DENZO was fine, meaningful scaling with SCALEPACK was not possible. Discussion with the beamline scientist led to the conclusion that a beamline shutter failure was the source of the problem. The only processable dataset was a high resolution inhibitor-complex dataset to 2.3 Å. The diffraction of all crystals was strongly anisotropic. Data collection details are given in Table <ref type="table">1</ref>.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Phases to 4 Å resolution for this structure were obtained in a MIRAS experiment at BAMline ( BESSY, Berlin ) using a Pt-and a Hg-derivate. Exploiting a sixfold non-crystallographic symmetry density modification and phase extension using the inhibitor-complex dataset from the above measurement resulted in well interpretable maps. Refinement is on the way, the actual status is summarized in Table <ref type="table" target="#tab_1">2</ref>. encoded by pSM19035 from Streptococcus pyogenes Experiment number: LS1958 Beamline: Date of experiment: from: 16/06/01 to: 18/06/01 Date of report: 27/08/01 Shifts: Local contact(s): Gordon Leonard Received at ESRF: Names and affiliations of applicants (* indicates experimentalists): Meinhart Anton Institut für Kristallographie / Chemie Freie Universität Berlin Takustraße 6 D 14195 BERLIN GERMANY</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>The plasmid addiction system ε,ζ ensures stable inheritance of plasmids encoding the genes ε and ζ. Loss of these genes leads to programmed cell death. Both proteins form a non-toxic ε 2 ζ 2 -heterotetramer. Comparison to structurally related proteins revealed ζ to be a phosphotransferase. Catalytically relevant residues were proved by site-directed mutagenesis.</p><p>To demonstrate conserved tertiary structure, X-ray diffraction studies on protein crystals of mutated ζ protein were performed.</p><p>Collected data revealed dramatic radiation damage. A decrease in atomic occupancy of carboxylic groups from glutamate and aspartate side chains was observed. This phenomenon is in agreement with the results of Burmeister <ref type="bibr" target="#b0">[1]</ref>. Therefore refinement converged at unusual high R-values (see Table <ref type="table" target="#tab_0">1</ref>), although the achieved resolution was much higher as observed up to now.</p><p>Data-collection statistics and refinement details are given in Table <ref type="table" target="#tab_0">1</ref>. 1.07 a) R lin.: (Σ(I-&lt;I&gt;))/ΣI a <ref type="bibr" target="#b0">[1]</ref> Burmeister, W.P. <ref type="bibr">(2000)</ref>. Structural changes in a cryo-cooled protein crystal owing to radiation damage. Acta Cryst., D56., 328-341.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experiment title:</head><p>Crystal structure at atomic resolution of HLA-B*2709 in complex with a defined nonameric peptide We succeeded in refolding and crystallising B*2709 in complex with a defined nonameric model peptide (m9). Crystals were obtained by cross-seeding with crystals of subtype B*2705 obtained earlier, in complex with the same nonameric peptide. Data collection at beamline ID14-4 resulted in a native data set complete to 1.09 Å resolution (Table <ref type="table" target="#tab_0">1</ref>). The phase problem was solved by Molecular Replacement, and the structure has been refined to an R factor of 12.3% (R free 14.8%).</p><p>A comparative analysis of the structures of B*2709 (obtained from the data collection described here) and of B*2705 (data collected in June 2000 at beamline ID13, ESRF, exp. no. TC-88) is in progress and is expected to shed light on the role of HLA-B27 in arthritic diseases. As the only structure of a HLA-B27 subtype available so far contains a mixture of peptides, our structures with defined peptides will also provide more detailed insights into the characteristic peptide binding behaviour of HLA-B27. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>DNA helicases are ubiquitous enzymes required for DNA replication, recombination, transcription and repair, for RNA translation, splicing of mRNA and assembly of ribisomes. We have determined a high-resolution Xray structure (2.4 Å) of an intact, full-length hexameric helicase -DNA helicase RepA. The hexamer shows an annular structure with 6-fold rotational symmetry and a ~ 17 Å wide central hole which suggests that ssDNA may be threaded during unwinding <ref type="bibr" target="#b0">[1]</ref>. The elucidation of the structure information of RepA helicase can be used to select specific helicase inhibitors and further give rise to the development of antibiotics and drugs. By biochemical screening, we recently found potential inhibitors for RepA helicase. In order to understand both the mechanism by which duplex DNA is unwound and by which inhibitors block cellular function, structural information is needed to elucidate in detail the interaction between inhibitors or DNA and RepA.</p><p>Data of a RepA/inhibitor complex was collected to 2.4 Å. Data-collection statistics and refinement details are given in Table <ref type="table" target="#tab_0">1</ref>. Further refinement and structure analysis is underway.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1. Data collection and refinement statistics</head><p>References:</p><p>1. Niedenzu, T., Röleke, D., Bains, G., Scherzinger, E., and Saenger, W. ( <ref type="formula">2001</ref>) J. Mol. Biol. 306, 479-487. Experiment title: Crystal Structure of human Pirin Experiment number: LS 1958 Beamline: Date of experiment: from: 16/06/01 to: 18/06/01 Date of report: 28/08/01 Shifts: Local contact(s): Gordon Leonard Received at ESRF: Names and affiliations of applicants (* indicates experimentalists): Uwe Mueller et al. Proteinstrukturfabrik c/o BESSY GmbH Albert-Einstein-Str. 15 12489Berlin Germany</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>N-and C-terminal tagged Human Pirin (Swiss-Prot acc. no. O00625) could be expressed, overproduced, purified and crystallized using an integrated approach for three dimensional structure solution, which are developed and utilized within the German structural genomics initiative "Proteinstrukturfabrik" <ref type="bibr" target="#b0">[1]</ref>.</p><p>This protein crystallized as thin needles of dimensions of 30x30x200 µ 3 and diffracted at ESRF-Beamline 14-4 afte establishing suitable cryo-conditions to a maximum resolution of 2.2 Å. Since no derivate for MAD-phasing was available, using the optained data the structure solution is not possible. Futher attempts in order to produce an Se-Met-Derivative Crystal are currently performed by PSF scientists. The spacegroup is C222 1 (#20, orthorhombic) and the cell parameters are a = 140.8 Å, b = 235.7 Å, c = 89.0 Å. Three monomers in the asymmetric unit are observed.</p><p>Although these three datasets were measured, phasing was only possible using the SAD method with the peak dataset. The program SOLVE (Terwilliger, Acta Cryst. D55, 849 (1999)) was not able to distinguish between peaks and noise with all three datasets but found all 9 non-terminal selenium sites when only the peak dataset was used. Phase improvement by running RESOLVE and NCS averaging improved the electron density in a way that allowed placing helices, strands and loops as well as identifying sidechains.</p><p>The biological unit, a hexamer built of two trimers on top of each other, is formed by a crystallographic two-fold rotation axis. However, the three-fold axis between the trimer could be used for non-crystallographic symmetry averaging.</p><p>Currently the structure is in the refinement state.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Names and affiliations of applicants (* indicates experimentalists):Martin Hülsmeyer and Roman C. Hillig, Charité, Institut für Immungenetik, Humboldt Universität zu Berlin, Berlin, Germany *Timm Maier and Norbert Sträter, Institut für Kristallographie, Freie Universität, Berlin, GermanyReport:The human MHC class I molecule HLA-B27 shows a strong association with spondyloarthropathies, a group of closely related inflammatory arthritic diseases, the most common of which is ankylosing spondylitis (AS). This connection has been recognized almost 30 years ago, but the underlying mechanism is still not understood. Within the last few years, a number of subtypes of B27 have been described and characterised concerning their association with disease. Remarkably, there are two subtypes, B*2706 and B*2709, who show no disease association. As B*2709 shows only one amino acid difference compared to the disease-associated subtype B*2705, we initiated a comparative structural analysis of B*2705 and B*2709.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><figDesc>.s. deviations from stereochemical target values r.m.s.d., bond lengths (Å) 0.0091 r.m.s.d., bond angles (°) 1.37 a) R sym = ∑|I-〈I 〉| / ∑I , where 〈I 〉 is the average intensity over symmetry equivalent reflections. b) R cryst and R free = ∑||F o |-|F c || / ∑|F o | , where F o and F c are the observed and calculated structure factor amplitudes. For the calculation of R free , 5% of the reflection data were selected in thin resolution shells and omitted from refinement.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Data collection statistics</figDesc><table><row><cell>Space group</cell><cell>P3 1 21</cell></row><row><cell>Unit Cell</cell><cell>a=b=163.9Å c=244.7Å, α=β=90°, γ=120°</cell></row><row><cell>Resolution</cell><cell>30 -2.2 Å</cell></row><row><cell>Total Observations</cell><cell>2 083 018</cell></row><row><cell>Unique Observations</cell><cell>192 852</cell></row><row><cell>R sym</cell><cell>0.069</cell></row><row><cell>I/σ ( final shell )</cell><cell>4.7</cell></row><row><cell>Completeness</cell><cell>99.9 %</cell></row><row><cell>Mosaicity (°)</cell><cell>0.464</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc>An inactive ζ(R171S) mutant of the plasmid addiction system ε,ζ</figDesc><table><row><cell>. Refinement Statistics</cell><cell></cell></row><row><cell>Resolution</cell><cell>30 -2.25 Å</cell></row><row><cell>Solvent Content</cell><cell>55 %</cell></row><row><cell>R cryst / R free</cell><cell>21% / 26 %</cell></row><row><cell>rmsd bonds</cell><cell>0.010 Å</cell></row><row><cell>rmsd angles</cell><cell>1.54°</cell></row><row><cell>B aver</cell><cell>40.5 Å²</cell></row><row><cell>No. of Protein Atoms</cell><cell>23232</cell></row><row><cell cols="2">No. of Non-Protein / Non-Solvent Atoms 261</cell></row><row><cell>No. of Solvent Atoms</cell><cell></cell></row></table><note><p>β-Hexosaminidase is a lysosomal hydrolase that cleaves terminal non-reducing β-Nacetylhexosamines from a broad range of substances e.g. glycolipids and glycoproteins. Mammalian β-hexosaminidases occur as two major isoforms: HexA, a heterodimer of the closely related α-and β-chains, and HexB, a homodimer ( ββ ). Mutations in the gene encoding the β-chain of β-hexosaminidase are the primary cause of Sandhoff disease, a fatal inborn error of metabolism. Datasets were collected in high and low resolution shells for different crystals of human β-hexosaminidase (non-inhibitor bound, previous datasets were not processable, see accompanying report) recombinantly expressed in insect cells. Data collection statistics for one high resolution dataset are given in Table1</p><p>. Refinement of the structure is currently focussed on the inhibitor-complex ( see accompanying report ).</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 1 .</head><label>1</label><figDesc>Data collection and refinement statistics</figDesc><table><row><cell>Data collection</cell><cell></cell></row><row><cell>space group</cell><cell>P2 1 2 1 2 1</cell></row><row><cell>unit cell (Å)</cell><cell></cell></row><row><cell>a:</cell><cell>59.71</cell></row><row><cell>b:</cell><cell>80.03</cell></row><row><cell>c:</cell><cell>193.49</cell></row><row><cell>Resolution (Å)</cell><cell>20.00-1.55</cell></row><row><cell>Total observations</cell><cell>1 470 220</cell></row><row><cell>Unique reflections R sym a)</cell><cell>134 527 0.068</cell></row><row><cell>mean I/σ</cell><cell>16.7</cell></row><row><cell>R sym (final shell)</cell><cell>0.493</cell></row><row><cell>mean I/σ (final shell)</cell><cell>3.97</cell></row><row><cell>Completeness</cell><cell>0.995</cell></row><row><cell>Completeness (final shell)</cell><cell>1.0</cell></row><row><cell>Model refinement</cell><cell></cell></row><row><cell>R work / R free</cell><cell>0.218 / 0.216</cell></row><row><cell>R.m.s.d., bond length (Å)</cell><cell>0.004</cell></row></table><note><p>R.m.s.d., bond angles (°)   </p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 1</head><label>1</label><figDesc>Diffraction data statistics</figDesc><table><row><cell>Data collection</cell><cell>HLA-B*2709 : m9</cell></row><row><cell>X-ray source</cell><cell>ID14-4 (ESRF)</cell></row><row><cell>Space group</cell><cell>P2 1 2 1 2 1</cell></row><row><cell>Unit cell</cell><cell>a = 50.8 Å</cell></row><row><cell></cell><cell>b = 82.5 Å</cell></row><row><cell></cell><cell>c = 110.7 Å</cell></row><row><cell>Resolution (Å)</cell><cell>19.3 -1.1</cell></row><row><cell>Resolution outer shell (Å)</cell><cell>1.13 -1.10</cell></row><row><cell>No. of unique reflections</cell><cell>182507</cell></row><row><cell>Multiplicity</cell><cell>4.7 (2.9)</cell></row><row><cell>Completeness (%)</cell><cell>96.7 (96.9)</cell></row><row><cell>I/σ</cell><cell>12.9 (3.1)</cell></row><row><cell>R sym</cell><cell>0.091 (0.353)</cell></row><row><cell>Refinement</cell><cell></cell></row><row><cell cols="2">Refelctions (work / test set) 176285 / 5660</cell></row><row><cell cols="2">No. of non-hydrogen atoms 4339</cell></row><row><cell>R cryst</cell><cell>0.123 (0.17)</cell></row><row><cell>R free</cell><cell>0.148 (0.17)</cell></row><row><cell cols="2">Values in brackets refer to the highest resolution</cell></row><row><cell>shell.</cell><cell></cell></row></table><note><p>Received at ESRF:</p><p>Names and affiliations of applicants (* indicates experimentalists):</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 1 . Data collection and refinement statistics Data collection</head><label>1</label><figDesc>) R sym = ∑|I-〈I 〉| / ∑I , where 〈I 〉 is the average intensity over symmetry equivalent reflections.Protein crystals containing SeMet as heavy atom derivative and NAD as ligand were measured at ESRF beamline ID14-4. The fluorescence scan showed a clear peak. The best crystal had satisfying statistics up to a resolution of 2.9 Å and a complete MAD dataset was</figDesc><table><row><cell>space group</cell></row></table><note><p>a</p></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Shifts:</p><p>1</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Local contact(s):</head><p>Gordon Leonard </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>Termination of protein biosynthesis and release of the nascent polypeptide chain is signaled by the presence of an in-frame stop codon at the aminoacyl (A) site of the ribosome. The process of translation termination is universal and is mediated by protein release factors. RF1 from Thermus thermophilus is unrelated in primary structure to the omnipotent, eukaryotic eRF1 suggesting the existence of two distinct protein families. Moreover, it is expected that these two families will adopt different protein architectures, since a secondary structure prediction indicated a pattern that would be inconsistent with eRF1 <ref type="bibr" target="#b3">(Goldstein et al., 1970;</ref><ref type="bibr" target="#b5">Konecki et al., 1977;</ref><ref type="bibr" target="#b2">Frolova et al., 1994)</ref>. To provide insight into the structure of the prokaryotic RF1 from T. thermophilus and for comparison to the eukaryotic eRF1 structure <ref type="bibr" target="#b4">(Song et al., 2000)</ref> MAD data from crystals of T. thermophilus RF1 were collected in collaboration with the group of Prof. M. Sprinzl at the University of Bayreuth, Germany.</p><p>Datasets were collected at the peak (0.9795 Å) and the inflection point (0.9797 Å) of selenomethionine (no time was left for high-energy remote). The crystal diffracted up to a maximal resolution of 2.2 Å and belongs to the rhombohedral space group R32 with cell parameters a = 109.2 Å and c = 152.1 Å. The peak dataset is 94.6% complete with Rsym of 6.3%, 914,868 total reflections and 32,408 unique reflections. 3 of 11 selenomethionine sites were found by SAD with the peak dataset. No further sites were found with MAD by using both datasets (peak and inflection point) and map resulting from this method also showed no improvement. After initial tracing of the electron density it appears as if the map represented</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">An integrated approach to structural genomics</title>
		<author>
			<persName><forename type="first">Udo</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Juergen</forename><surname>Frevert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Klaus-Peter</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gerd</forename><surname>Illing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cornelia</forename><surname>Maurer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hartmut</forename><surname>Oschkinat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wolfram</forename><surname>Saenger</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0079-6107(00)00009-2</idno>
	</analytic>
	<monogr>
		<title level="j">Progress in Biophysics and Molecular Biology</title>
		<title level="j" type="abbrev">Progress in Biophysics and Molecular Biology</title>
		<idno type="ISSN">0079-6107</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="347" to="362" />
			<date type="published" when="2000-06">2000</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Heinemann, U., J. Frevert, et al. (2000). &quot;An integrated approach to structural genomics.&quot; Prog. Biophys Mol. Biol. 73(5): 347-362.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Real-Time Observation of Protein Dense Liquid Cluster Evolution during Nucleation in Protein Crystallization</title>
		<idno type="DOI">10.1021/acs.cgd.6b01826.s001</idno>
		<imprint>
			<date>null</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">only a fragment of the protein. We cannot exclude the possibility, therefore, that partial degradation of the SeMet-RF1 protein occurred during the crystallization experiment. At this time it is not known which part or domain of the protein is seen in the map.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor</title>
		<author>
			<persName><forename type="first">Lyudmila</forename><surname>Frolova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xavier</forename><surname>Le Goff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hanne</forename><forename type="middle">H</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sergey</forename><surname>Cheperegin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gabriele</forename><surname>Drugeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michel</forename><surname>Kress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Inga</forename><surname>Arman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anne-Lise</forename><surname>Haenni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jullo</forename><forename type="middle">E</forename><surname>Celis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Michel</forename><surname>Phllippe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Just</forename><surname>Justesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lev</forename><surname>Kisselev</surname></persName>
		</author>
		<idno type="DOI">10.1038/372701a0</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="issue">6507</biblScope>
			<biblScope unit="page" from="701" to="703" />
			<date type="published" when="1994-12">1994</date>
			<publisher>Springer Science and Business Media LLC</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Frolova, L., Le Goff, X., Rasmussen, H.H., Cheperegin, S., Drugeon, G., Kress, M., Arman, I., Haenni, A.L., Celis, J.E., Philippe, M., et al. (1994) Nature, 372, 701-703</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Peptide Chain Termination with Mammalian Release Factor</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Beaudet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Caskey</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.67.1.99</idno>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proc. Natl. Acad. Sci. U.S.A.</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="99" to="106" />
			<date type="published" when="1970-09">1970</date>
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Goldstein, J.L., Beaudet, A.L. and Caskey, C.T. (1970) Proc. Natl. Acad. Sci. USA, 67, 99- 106</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The Crystal Structure of Human Eukaryotic Release Factor eRF1—Mechanism of Stop Codon Recognition and Peptidyl-tRNA Hydrolysis</title>
		<author>
			<persName><forename type="first">Haiwei</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pierre</forename><surname>Mugnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Amit</forename><forename type="middle">K</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Helen</forename><forename type="middle">M</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">David</forename><forename type="middle">R</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mick</forename><forename type="middle">F</forename><surname>Tuite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Brian</forename><forename type="middle">A</forename><surname>Hemmings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">David</forename><surname>Barford</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0092-8674(00)80667-4</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<title level="j" type="abbrev">Cell</title>
		<idno type="ISSN">0092-8674</idno>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="311" to="321" />
			<date type="published" when="2000-02">2000</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Song, H., Mugnier, P., Das, A.K., Webb, H.M., Evans, D.R., Tuite, M.F., Hemmings, B.A. and Barford, D. (2000) Cell, 100, 311-321</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Characterization of reticulocyte release factor.</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Konecki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Aune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Caskey</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0021-9258(17)40191-8</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">Journal of Biological Chemistry</title>
		<idno type="ISSN">0021-9258</idno>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="4514" to="4520" />
			<date type="published" when="1977-07">1977</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>Experiment title: Human Nicotinamide Mononucleotide Adenylyltransferase (NMNAT) Experiment number: LS1958 Beamline: ID14-4 Date of experiment: 16.06.01 Date of report: 27.08.01</note>
	<note type="raw_reference">Konecki, D.S., Aune, K.C., Tate, W. and Caskey, C.T. (1977) J. Biol. Chem., 252, 4514-4520 Experiment title: Human Nicotinamide Mononucleotide Adenylyltransferase (NMNAT) Experiment number: LS1958 Beamline: ID14-4 Date of experiment: 16.06.01 Date of report: 27.08.01</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Remote Access Experiments at the Macromolecular Crystallography Beamlines of the ESRF</title>
		<author>
			<persName><forename type="first">Jose</forename><surname>Gabadinho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">David</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gordon</forename><surname>Leonard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Elspeth</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stéphanie</forename><surname>Monaco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xavier</forename><surname>Thibault</surname></persName>
		</author>
		<idno type="DOI">10.1080/08940880802406075</idno>
	</analytic>
	<monogr>
		<title level="j">Synchrotron Radiation News</title>
		<title level="j" type="abbrev">Synchrotron Radiation News</title>
		<idno type="ISSN">0894-0886</idno>
		<idno type="ISSNe">1931-7344</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="24" to="29" />
			<date type="published" when="2008-09-26" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note>* indicates experimentalists</note>
	<note type="raw_reference">Shifts: 1 Local contact(s): Gordon Leonard Received at ESRF: Names and affiliations of applicants (* indicates experimentalists):</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Program and Abstracts of the 9th Transgenic Technology Meeting (TT2010)</title>
		<author>
			<persName><forename type="first">Erik</forename><surname>Werner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Crystallogrpahy</forename><surname>Group</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Max</forename><forename type="middle">Delbrück</forename><surname>Center For Molecular</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Robert-Rössle-Str</forename><surname>Medicine</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11248-010-9366-9</idno>
	</analytic>
	<monogr>
		<title level="j">Transgenic Research</title>
		<title level="j" type="abbrev">Transgenic Res</title>
		<editor>
			<persName><forename type="first">Bessy</forename><surname>Gmbh</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Albert-Einstein-Straße-15</forename></persName>
		</editor>
		<editor>
			<persName><forename type="first">D-12489</forename></persName>
		</editor>
		<idno type="ISSN">0962-8819</idno>
		<idno type="ISSNe">1573-9368</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="307" to="355" />
			<date type="published" when="1997">1997</date>
			<publisher>Springer Science and Business Media LLC</publisher>
			<pubPlace>Berlin, Germany Report</pubPlace>
		</imprint>
	</monogr>
	<note>D-13092 Berlin, Germany Uwe Müller, Protein Structure Factory</note>
	<note type="raw_reference">Erik Werner, Crystallogrpahy Group, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str.10, D-13092 Berlin, Germany Uwe Müller, Protein Structure Factory, c/o Bessy GmbH Albert-Einstein-Straße-15, D-12489 Berlin, Germany Report: Human nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1) is an oligomeric enzyme consisting of identical 33 kDa subunits. It catalyses the final step in the biosynthesis of nicotinamide-adenine dinucleotide, the major coenzyme in cellular redox reactions (Magni et al., Meth. Enzymol. 280, 241 (1997)):</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Figure 3. Testing the model.</title>
		<idno type="DOI">10.7554/elife.06303.006</idno>
	</analytic>
	<monogr>
		<title level="j">Bioch. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">257</biblScope>
			<biblScope unit="page">1550</biblScope>
			<date type="published" when="1995">2000. 1995</date>
			<publisher>eLife Sciences Publications, Ltd</publisher>
		</imprint>
	</monogr>
	<note>NAD + also appears to be an important constituent of several intracellular signalling pathways (Ziegler, Euro J. Biochem.</note>
	<note type="raw_reference">NAD + also appears to be an important constituent of several intracellular signalling pathways (Ziegler, Euro. J. Biochem. 257, 1550 (2000)). NMNAT has been proposed as a chemothera- peutical drug target, since its activity is down-regulated in tumor cells (Emanuelli et al., Bioch. Pharmacol. 49, 575 (1995))</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
